Fixel Chair Dr. Malu Tansey co-authors a News and Views article in Nature about Infection and Parkinson’s Disease.
All Posts
Ayse Gunduz, PhD, earns White House honor
Ayse Gunduz PhD, PI of the Brain Mapping laboratory at the Fixel Institute and member of the MBI receives white house recognition for her science
Fixel Investigator Gives Tedx Talk on Phishing
Fixel investigator Daniela Oliveira, PHD, researches how people with neurodegenerative diseases can get caught and more importantly can protect themselves from phishing scams.
Meet our first patient, Tyler Staab
Tyler Staab was the first patient seen at the Norman Fixel Institute for Neurological Diseases at UF Health, which opened its doors to the public on July 1, 2019. Tyler’s Hope for a Dystonia Cure has been one of the Fixel Institute and MBI’s biggest supporters over the years. The Fixel Institute’s faculty and staff…
For brain health, skip the supplements and focus on a healthy diet
Steven Dekosky, a Neurologist with the Fixel Institute for Neurological Diseases, explains to the Washington Post what’s known and what isn’t about supplements, nutrition and brain health
World-renowned neurogeneticist to join UF Health
On Sept. 1, renowned neurogeneticist Matthew Farrer, Ph.D., internationally recognized for his work on the genetics of Parkinson’s disease, will join UF Health, the University of Florida’s academic health center.
UF Health unveils new neurological facility
The new facility was created with the help of donors like the Lauren and Lee Fixel Family Foundation and Tyler’s Hope for a Dystonia Cure.
UF Health opens neurology institute
About 100 doctors, University of Florida faculty, patients and others on Wednesday attended the unveiling of the newly-built Norman Fixel Institute for Neurological Diseases at UF Health.
UF Health unveils innovative new facility to treat debilitating neurological conditions
The Norman Fixel Institute for Neurological Diseases at UF Health today unveiled its new, world-class clinical care and research building, marking its latest step in the pursuit of providing the nation’s most comprehensive and advanced care for Parkinson’s disease and other neurodegenerative disorders.
UF Health patient first to receive new gene therapy for neuromuscular disease since FDA approval
Karen Wright worked her way through the small gathering outside her 4-month-old daughter’s room in pediatric intensive care.